| Supriya Lifescience Ltd |
|
Registered Office:
207/208 Udyog Bhavan,Sonawala Road Goregaon (East)
,
Mumbai
-
400063
,
Maharashtra
, India.
Phone :
91-22-40332727 Fax:
Email : cs@supriyalifescience.com
Website : www.supriyalifescience.com
|
Initial public offering of 25,547,445* equity shares of face value of
 2 each ("Equity Shares") of Supriya Lifescience Limited ("The Company" or the "Issuer") for cash at a price of 274 per equity share ("Offer Price") aggregating to 700.00 crores, comprising a fresh issue of 7,299,270* equity shares aggregating to 200.00 crores ("Fresh Issue") and an offer for sale of 18,248,175* equity shares aggregating to 500.00 crores by Satish Waman Wagh (The "Promoter Selling Shareholder") (The "Offer for Sale", together with the fresh issue, the "Offer"). The offer will constitute 31.74% of the post-offer paid-up equity share capital.
*Subject to finalisation of basis of allotment
The face value of each equity share is 2 each. The offer price is 137 times the face value of the equity shares.
Bids can be made for a minimum of 54 equity shares and in multiples of 54 equity shares thereafter. |
| Issue |
Money Payable On |
|
| Opens On |
Closes On |
Application |
Allotment |
|
| 16-Dec-21 |
20-Dec-21 |
Rs274.00-0.00 |
Rs0.00-0.00 |
| Minimum Application for shares in Nos :54 Further Multiples of :54 |
| |
RsCr |
Lead Managers to the Issue |
|
| Project Cost |
200.00 |
|
| Project Financed through Current Offer |
700.00 |
|
| Post Issue Equity Share Capital |
16.10 |
|
| Issue Price |
Rs274.00 |
|
|